{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:00:05Z","timestamp":1793325605128,"version":"4.5.0"},"reference-count":41,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,8,2]]},"abstract":"<jats:p>Background: Varicella zoster virus (VZV) has been implicated in Alzheimer\u2019s disease (AD), and vaccination against shingles, caused by VZV, has been found to decrease the risk of AD\/dementia. VZV might reside latently in brain, and on reactivation might cause direct damage leading to AD, as proposed for herpes simplex virus type 1 (HSV-1), a virus strongly implicated in AD. Alternatively, shingles could induce neuroinflammation and thence, reactivation of HSV-1 in brain. Objective: To investigate these possibilities by comparing the effects of VZV and HSV-1 infection of cultured cells, and the action of VZV infection on cells quiescently infected with HSV-1. Methods: We infected human-induced neural stem cell (hiNSC) cultures with HSV-1 and\/or VZV and sought the presence of AD-related phenotypes such as amyloid-\u03b2 (A\u03b2) and P-tau accumulation, gliosis, and neuroinflammation. Results: Cells infected with VZV did not show the main AD characteristics, A\u03b2 and P-tau accumulation, which HSV-1 does cause, but did show gliosis and increased levels of pro-inflammatory cytokines, suggesting that VZV\u2019s action relating to AD\/dementia is indirect. Strikingly, we found that VZV infection of cells quiescently infected with HSV-1 causes reactivation of HSV-1 and consequent AD-like changes, including A\u03b2 and P-tau accumulation. Conclusion: Our results are consistent with the suggestion that shingles causes reactivation of HSV1 in brain and with the protective effects against AD of various vaccines, as well as the decrease in herpes labialis reported after certain types of vaccination. They support an indirect role for VZV in AD\/dementia via reactivation of HSV-1 in brain.<\/jats:p>","DOI":"10.3233\/jad-220287","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:47:53Z","timestamp":1655819273000},"page":"1189-1200","source":"Crossref","is-referenced-by-count":121,"title":["Potential Involvement of Varicella Zoster Virus in Alzheimer\u2019s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1"],"prefix":"10.1177","volume":"88","author":[{"given":"Dana M.","family":"Cairns","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, Tufts University, Medford, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth F.","family":"Itzhaki","sequence":"additional","affiliation":[{"name":"Institute of Population Ageing, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Tufts University, Medford, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220287_ref1","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The infectious etiology of Alzheimer\u2019s disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-220287_ref2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-021-01286-4","article-title":"Cognitive decline following acute viral infections: Literature review and projections for post-COVID-19","volume":"272","author":"Damiano","year":"2022","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-220287_ref3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-191337","article-title":"Associations of infectious agents with Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"75","author":"Ou","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220287_ref4","doi-asserted-by":"crossref","first-page":"16m11312","DOI":"10.4088\/JCP.16m11312","article-title":"Herpes zoster and dementia: A nationwide population-based cohort study","volume":"79","author":"Chen","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.3233\/JAD-220287_ref5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00406-020-01157-4","article-title":"Association of herpes zoster with dementia and effect of antiviral therapy on dementia: A population-based cohort study","volume":"271","author":"Bae","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-220287_ref6","doi-asserted-by":"crossref","first-page":"e045871","DOI":"10.1136\/bmjopen-2020-045871","article-title":"Shingles, Zostavax vaccination and risk of developing dementia: A nested case-control study-results from the UK Biobank cohort.","volume":"11","author":"Lophatananon","year":"2021","journal-title":"BMJ Open"},{"key":"10.3233\/JAD-220287_ref7","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.21873\/invivo.12622","article-title":"Herpes zoster vaccination reduces risk of dementia","volume":"35","author":"Lehrer","year":"2021","journal-title":"In Vivo"},{"key":"10.3233\/JAD-220287_ref8","doi-asserted-by":"crossref","first-page":"e0257405","DOI":"10.1371\/journal.pone.0257405","article-title":"Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts","volume":"16","author":"Scherrer","year":"2021","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220287_ref9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/infdis\/jiz560","article-title":"Varicella-zoster virus infection of primary human spinal astrocytes produces intracellular amylin, amyloid-beta, and an amyloidogenic extracellular environment","volume":"221","author":"Bubak","year":"2020","journal-title":"J Infect Dis"},{"key":"10.3233\/JAD-220287_ref10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jmv.1890330403","article-title":"Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains","volume":"33","author":"Jamieson","year":"1991","journal-title":"J Med Virol"},{"key":"10.3233\/JAD-220287_ref11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease","volume":"349","author":"Itzhaki","year":"1997","journal-title":"Lancet"},{"key":"10.3233\/JAD-220287_ref12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jmv.20271","article-title":"Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer\u2019s disease patients","volume":"75","author":"Wozniak","year":"2005","journal-title":"J Med Virol"},{"key":"10.3233\/JAD-220287_ref13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","article-title":"Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation","volume":"429","author":"Wozniak","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220287_ref14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2009-0963","article-title":"Alzheimer\u2019s disease-specific tau phosphorylation is induced by herpes simplex virus type 1","volume":"16","author":"Wozniak","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220287_ref15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.2449","article-title":"Herpes simplex virus type 1 DNA is located within Alzheimer\u2019s disease amyloid plaques","volume":"217","author":"Wozniak","year":"2009","journal-title":"J Pathol"},{"key":"10.3233\/JAD-220287_ref16","doi-asserted-by":"crossref","first-page":"e25152","DOI":"10.1371\/journal.pone.0025152","article-title":"Antivirals reduce the formation of key Alzheimer\u2019s disease molecules in cell cultures acutely infected with herpes simplex virus type 1.","volume":"6","author":"Wozniak","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220287_ref17","doi-asserted-by":"crossref","first-page":"eaay8828","DOI":"10.1126\/sciadv.aay8828","article-title":"A 3D human brain \u00c4\u00eclike tissue model of herpes-induced Alzheimer\u2019s disease","volume":"6","author":"Cairns","year":"2020","journal-title":"Sci Adv"},{"key":"10.3233\/JAD-220287_ref18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/jnnp.62.6.586","article-title":"Neurotropic viruses and Alzheimer\u2019s disease: A search for varicella zoster virus DNA by the polymerase chain reaction","volume":"62","author":"Lin","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220287_ref19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.10662","article-title":"Herpesviruses in brains in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"54","author":"Hemling","year":"2003","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-220287_ref21","first-page":"13","article-title":"Alzheimer\u2019s disease and herpes","volume":"167","author":"Itzhaki","year":"2002","journal-title":"CMAJ"},{"key":"10.3233\/JAD-220287_ref22","first-page":"1495","article-title":"Past exposure to vaccines and subsequent risk of Alzheimer\u2019s disease","volume":"165","author":"Verreault","year":"2001","journal-title":"CMAJ"},{"key":"10.3233\/JAD-220287_ref23","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1042\/bst019122s","article-title":"Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer\u2019s disease brain using polymerase chain reaction","volume":"19","author":"Jamieson","year":"1991","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-220287_ref24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.stemcr.2016.07.017","article-title":"Expandable and rapidly differentiating human induced neural stem cell lines for multiple tissue engineering applications","volume":"7","author":"Cairns","year":"2016","journal-title":"Stem Cell Rep"},{"key":"10.3233\/JAD-220287_ref25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nprot.2015.091","article-title":"bioengineered model of cortical brain tissue","volume":"10","author":"Chwalek","year":"2015","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-220287_ref26","doi-asserted-by":"crossref","first-page":"13811","DOI":"10.1073\/pnas.1324214111","article-title":"Bioengineered functional brain-like cortical tissue","volume":"111","author":"Tang-Schomer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220287_ref27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s007050050315","article-title":"Herpes simplex virus type 1 ICP-0 induces reactivation of pseudorabies virus from latently infected trigeminal ganglia explant cultures","volume":"143","author":"Smith","year":"1998","journal-title":"Arch Virol"},{"key":"10.3233\/JAD-220287_ref28","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1128\/JVI.75.7.3240-3249.2001","article-title":"ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency","volume":"75","author":"Halford","year":"2001","journal-title":"J Virol"},{"key":"10.3233\/JAD-220287_ref29","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/jvi.63.8.3513-3515.1989","article-title":"Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an latency system. }","volume":"63","author":"Harris","year":"1989","journal-title":"J Virol"},{"key":"10.3233\/JAD-220287_ref30","doi-asserted-by":"crossref","first-page":"658695","DOI":"10.3389\/fneur.2021.658695","article-title":"The potential role of herpes simplex virus type 1 and neuroinflammation in the pathogenesis of Alzheimer\u2019s disease","volume":"12","author":"Laval","year":"2021","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-220287_ref31","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S1473-3099(21)00258-9","article-title":"Should infectious diseases be targeted to prevent dementias?","volume":"21","author":"Bu","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.3233\/JAD-220287_ref32","doi-asserted-by":"crossref","first-page":"685863","DOI":"10.3389\/fnagi.2021.685863","article-title":"Can control infections slow down the progression of Alzheimer\u2019s disease? Talking about the role of infections in Alzheimer\u2019s disease","volume":"13","author":"Shi","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220287_ref33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s11845-021-02714-z","article-title":"Herpes simplex and herpes zoster viruses in COVID-19 patients","volume":"191","author":"Katz","year":"2022","journal-title":"Ir J Med Sci"},{"key":"10.3233\/JAD-220287_ref34","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s13555-021-00549-1","article-title":"Can COVID-19 increase the risk of herpes zoster? A narrative review","volume":"11","author":"Diez-Domingo","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.3233\/JAD-220287_ref35","first-page":"e18022","article-title":"COVID-19 and herpes simplex virus infection: A cross-sectional study","volume":"13","author":"Shanshal","year":"2021","journal-title":"Cureus"},{"key":"10.3233\/JAD-220287_ref36","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/bjd.19484","article-title":"Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19","volume":"183","author":"Xu","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.3233\/JAD-220287_ref37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","article-title":"High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19","volume":"51","author":"Simonnet","year":"2021","journal-title":"Infect Dis Now"},{"key":"10.3233\/JAD-220287_ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2151","article-title":"Does bacillus Calmette-Gu\u00e9rin vaccine prevent herpes simplex virus recurrences? A systematic review","volume":"31","author":"Pittet","year":"2021","journal-title":"Rev Med Virol"},{"key":"10.3233\/JAD-220287_ref39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3934\/microbiol.2021007","article-title":"Bacillus Calmette-Guerin (BCG): The adroit vaccine","volume":"7","author":"Adesanya","year":"2021","journal-title":"AIMS Microbiol"},{"key":"10.3233\/JAD-220287_ref40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jmv.1890320202","article-title":"Establishment of PCR for the early diagnosis of herpes simplex encephalitis","volume":"32","author":"Puchhammer-Stockl","year":"1990","journal-title":"J Med Virol"},{"key":"10.3233\/JAD-220287_ref41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41582-021-00596-4","article-title":"Does antiherpetic antiviral therapy reduce the risk of dementia?","volume":"18","author":"Itzhaki","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220287_ref42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-021-00950-0","article-title":"Antiherpetic drugs: A potential way to prevent Alzheimer\u2019s disease?","volume":"14","author":"Linard","year":"2022","journal-title":"Alzheimers Res Ther"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:27Z","timestamp":1777370787000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":41,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-220287","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742214143.793596722","asserted-by":"object"}]},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]}}}